Drugs / Cefazoline
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT01537380 | Mar 2012 → Apr 2015 | — | Nantes University Hospital | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03518463 | Jun → Jul 2017 | pregnancy disorder | Mbarara University of Science and Technology | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cefazoline | “Intravenous (IV) cefazoline 1g” NCT03518463 ↗ |
| Route | Intravenous | “cefazolin 4 g i.v. injection” PMID 29793587 ↗ Dec 2017 |